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Surgical TechniquesWe chose bilateral PAB to minimize risks of complete
repair of multiple VSDs in the neonatal period and to reduce
potential complications of neoaortic valve insufficiency or
root dilation. Palliation can improve physiology, cause
some VSDs to close or become restrictive, allow easier
technical repair of remaining VSDs, and limit aortic valve
insufficiency and root dilation. Recently, the use of Amplat-
zer septal occluder devices (St Jude Medical, Inc, St Paul,
Minn) has been described in older children with multiple
VSDs5; however, there have been no reports involving neo-
nates. The staged approach described here may be a viable
low-risk alternative for patients with TGA and multiple
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device exchangeTomasz A. Timek, MD, Robert L. Hooker, MD, Asghar Khaghani, MD, and William Merhi, MD, Grand
Rapids, MichAlong with the increasing use of long-term destination ther-
apy with left ventricular assist device (LVAD) support has
come an increasing incidence of pump thrombosis and an
anticipated growing need for pump exchange in high-risk
patients. Pump exchange is complicated by multiple patient
comorbid conditions and previous cardiac surgical proce-
dures. We describe here a novel hybrid technique for
pump exchange avoiding a resternotomy.
CLINICAL SUMMARY
An 80-year-old man with a HeartMate II LVAD (Thora-
tec Corporation, Pleasanton, Calif) that had been implanted
in June of 2008 was seen in 2011 with fatigue, lightheaded-
ness, and palpitations. LVAD interrogation revealed flows
of 12 to 15 L/min, with increase in power to 12 to 17W. De-
spite intensified anticoagulation and eptifibatide infusions,
the patient had multiple admissions for hemolytic anemia
and pump thrombosis. He was evaluated for pump replace-
ment; however, this procedure was refused at 2 centersbecause of his advanced age and severe chronic obstructive
pulmonary disease (forced expiratory volume in 1 second of
1.2 L). The outflow graft of the device was directly behind
the sternum, and the patient also had severe bullae sur-
rounding his outflow graft, preventing a thoracotomy. A hy-
brid surgical interventional approach was therefore
undertaken. Surgery was performed in a hybrid operating
room with the patient under general anesthesia and with
transesophageal echocardiographic monitoring. With the
patient in the supine position, preparation for cardiopulmo-
nary bypass was performed through direct right common
femoral artery (19F cannula) and vein (22F cannula) cannu-
lation. Percutaneous access was gained in the left femoral
artery with a 12F sheath. Incisions were made subxiphoid
in the midline for access to the outflow pump connection
and left subcostal for access to the inflow connection
(Figure 1). Subsequently, full cardiopulmonary bypass
was initiated, with decompression of the heart visualized
by transesophageal echocardiography. A 20- 3 40-mm
Z-Med balloon (B. Braun Interventional Systems Inc, Beth-
lehem, Pa) was then advanced retrograde into the outflow
graft. Balloon inflation resulted in complete occlusion of
the outflow graft and facilitated pump exchange (Figure 2,
A). Extensive mobilization of the threaded pump connec-
tions was not needed because of endovascular control of
the outflow graft, minimizing surgical trauma. The drive
line of the original device was mobilized through the surgi-
cal incision and subsequently transected in the field at ex-
plantation. The drive line of the new device was tunneledery c March 2013
FIGURE 1. Surgical exposure through subxiphoid (A) and left subcostal (B) incisions for access to the outflow and inflow portions of the left ventricular
assist device.
Surgical Techniquesto the left side of the abdomen to achieve better positioning
and avoid contamination from the previous subcutaneous
tunnel on the right. The remaining portion of the original
drive line was removed at the level of the skin after all inci-
sions were closed. The exit wound was left open and
packed. Deairing was accomplished retrograde by balloon
deflation and a percutaneous vent in the outflow graft with
a pigtail catheter (Figure 2, B). Complete deairing of the
heart was confirmed on transesophageal echocardiogra-
phy. Examination of the explanted device revealed
a thrombus in the rotor unit. The patient was extubated
within 6 hours of the procedure. He had an uncomplicated
postoperative course and was discharged home 14 days
after surgery. The surgical incisions intraoperatively and
6 months after surgery are shown in Figure 3. The patient
has continued a very active lifestyle, without subsequent
device malfunctions.FIGURE 2. A, Inflation of balloon in outflow graft to facilitate device rem
The Journal of Thoracic and CaDISCUSSION
Mechanical support with implantable ventricular assist
devices has revolutionized the treatment of end-stage heart
failure. With increasing transplant waiting times and grow-
ing emphasis on destination therapy,1 patients with ventric-
ular assist devices are increasingly exposed to device
malfunctions necessitating pump exchange. These proce-
dures can pose significant risks because of possible need
for resternotomy, injury to unsupported right ventricle,
bleeding, air embolism, and multiple patient comorbidities.
We describe a minimally invasive approach of exchanging
the HeartMate II LVAD through a hybrid approach in the
context of a heart team. A multidisciplinary interventional
and surgical approach permitted a controlled exchange of
the device without resternotomy while ensuring safety of
the procedure. A similar method of deairing the device
through an intra-aortic catheter has been describedoval. B, Placement of deairing pigtail catheter after device exchange.
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FIGURE 3. Surgical incisions after skin approximation (A) and 6 months after surgery (B).
Surgical Techniquespreviously2; however, the addition of balloon occlusion of
the outflow graft allowed controlled exchange of the device
without the need to surgically control and clamp the graft,3
reducing surgical dissection and potential morbidity. Place-
ment of a Foley catheter into the outflowgraft4 offers another
option of controlling back bleeding from the aorta; however,
connecting the outflow graft to the new device can be made
difficult by uncontrolled bleeding because the Foley catheter
must be removed. Furthermore, deairing of the outflow graft
is more difficult with this approach, whereas endovascular
control facilitates this process. We advocate a combinedFrom the Department of Chest Surgery, NHO Okayama Medical Center, Okayama,
Japan.
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more than 80 yearsHisayuki Shigematsu, MD, Akio Andou, MD, and Ryohei Higashi, MD, Okayama, JapanSecondary pneumothorax in elderly patients is usually
a refractory condition and sometimes leads to a fatal outcome
because of underlying diffuse lung disease, such as emphy-
sema and interstitial pneumonia. Surgical approaches should
be considered for these patients after failure of chest drainage
or pleurodesis; however, surgeons hesitate to apply surgicaltreatment because of concerns related to operative mortality
and morbidity. We describe 11 patients aged more than 80
years with secondary pneumothorax who were successfully
treated with surgical approaches.CLINICAL SUMMARY
A total of 171 patients with primary or secondary sponta-
neous pneumothorax underwent surgical treatment at the
NHO Okayama Medical Center between January 2005
and March 2012. Eleven patients (6%) were aged more
than 80 years with secondary pneumothorax. Table 1 sum-
marizes the clinical features of these patients. All patients
were male, and the median age at the time of surgery was
81 years (range, 80-95 years). Ten patients had severe em-
physema, 2 of whom were also diagnosed with interstitial
pneumonia. Two patients were receiving home oxygenery c March 2013
